{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:29:36Z","timestamp":1773797376940,"version":"3.50.1"},"reference-count":26,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"3","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>Background: To determine the efficacy of tumour markers in conjunction with serum helper T-cell 1 (Th1) and helper T-cell 2 (Th2) cytokines for the detection of HR-HPV-positive cervical cancer. Methods: 49 patients with HR-HPV-positive benign cervical diseases of the same age group who were admitted to the hospital between January 2020 and June 2024 were chosen as the control group, and 49 patients with HR-HPV-positive cervical cancer were chosen as the study group. Serum Th1\/Th2 cytokine levels of patients with various clinicopathological characteristics in the study group were compared with the basic data, tumour markers, and serum Th1\/Th2 cytokines [interleukin (IL)-10, IL-6, interferon-g (IFN-g), and tumour necrosis factor-a (TNF-&lt;span style=\"color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);\"&gt;\u03b1&lt;\/span&gt;)] and tumour markers between the two groups. The association between tumour markers and serum Th1\/Th2 cytokine levels in patients with HR-HPV-positive cervical cancer was examined using Pearson correlation analysis. Results: International Federation of Obstetrics and Gynecology (FIGO) stages III-IV patients in the study group had greater serum levels of IL-10, IL-6, IFN-g, and TNF-&lt;span style=\"color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);\"&gt;\u03b1&lt;\/span&gt; than the control group (P&amp;lt; 0.05), and the levels of these substances in the patients with a myometrial invasion depth 1\/2 were all higher than in the patients with a myometrial invasion depth &amp;lt;1\/2 (P&amp;lt; 0.05). SCC-Ag, CA199, and there was a significant correlation (P&amp;lt; 0.05) between CYFRA21-1 levels and blood levels of IL-10, IL-6, IFN-g, and TNF-&lt;span style=\"color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);\"&gt;\u03b1&lt;\/span&gt; in patients with HR-HPV-positive cervical cancer. The AUCs of IL-10, IL-6, IFN-g and TNF-&lt;span style=\"color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);\"&gt;\u03b1&lt;\/span&gt; for the single diagnosis of HR-HPV-positive cervical cancer were 0.809, 0.773, 0.801 and 0.794, respectively, and the AUCs of SCC-Ag, CA199 and CYFRA21-1 for the single diagnosis of HR-HPV-positive cervical cancer were 0.831 and 0, respectively. 728, 0.789. The AUC of the combined diagnosis of HR-HPV-positive cervical cancer by serum IL-10, IL-6, IFN-g, TNF-&lt;span style=\"color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);\"&gt;\u03b1&lt;\/span&gt;, SCC-Ag, CA199, and CYFRA21-1 was 0.927. The AUC of the combined diagnosis was greater than that of the individual diagnosis of each index (Z = 2 .1 16, 2.690, 2.341, 2.565, 1.957, 3.351, 2.631, P= 0.034, 0.007, 0.019, 0.010, 0.039, 0.001, 0.009). Conclusions: The combined detection of serum Th1\/Th2 cytokine imbalance (elevated IL-6 and IL-10) and tumour markers (SCC, CA125) can significantly improve the diagnostic accuracy of HR-HPV-positive cervical cancer and provide a high-value serological auxiliary basis for the early identification of cervical cancer progression.<\/jats:p>","DOI":"10.5937\/jomb0-59352","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T08:01:37Z","timestamp":1756195297000},"page":"579-585","source":"Crossref","is-referenced-by-count":0,"title":["The application value of serum Th1\/Th2 cytokines combined with tumour markers in the diagnosis of HR-HPV-positive cervical cancer"],"prefix":"10.5937","volume":"45","author":[{"given":"Xia","family":"Cao","sequence":"first","affiliation":[{"name":"Danyang Maternal and Child Health Care Hospital, Department of Gynaecology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Ezhou Central Hospital, Department of Oncology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingpo","family":"Zhang","sequence":"additional","affiliation":[{"name":"First Hospital of Hebei Medical University, Obstetrics and Gynaecology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodang","family":"Zhong","sequence":"additional","affiliation":[{"name":"First Hospital of Hebei Medical University, Obstetrics and Gynaecology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Hu","sequence":"additional","affiliation":[{"name":"Huazhong University of Science and Technology, Hubei Cancer Hospital, Department of Gynaecological Oncology, Tongji Medical College, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Shiri Aghbash P , Rasizadeh R, Sadri Nahand J, Bannazadeh Baghi H. The role of immune cells and inflammasomes in Modulating cytokine responses in HPV-Related cervical cancer. Int Immunopharmacol 2025 Jan 3; 145: 113625;","DOI":"10.1016\/j.intimp.2024.113625"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Xu HH, Xie Y Y Jun-Gan, Yang Z, Han QY Dynamic changes of soluble HLA-G and cytokine plasma levels in cervical cancer patients: potential role in cancer progression and immunotherapy. J Cancer Res Clin Oncol 2023 Jul 149(8): 4195-204;","DOI":"10.1007\/s00432-022-04331-4"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ha JL, Kaser E, Guan T, Mayberry TG, Smith LA, D'mello K, Bai Q, Wakefield MR, Dong L, Fang Y Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1. Med Oncol 2024 Jan 28; 41(3): 65;","DOI":"10.1007\/s12032-023-02276-3"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Fourie L, Christowitz C, Eksteen C, van der Merwe H, Botha H, Venter C, Engelbrecht AM. Inflammation and thrombotic risk in late-stage cervical cancer: An exploratory study of coagulation and cytokine profiles in a South African cohort. Cytokine 2024 Dec; 184: 156782;","DOI":"10.1016\/j.cyto.2024.156782"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Yu C, Wang J, Li Y TRIM8 Promotes Proliferation, Invasion, and Migration of Cervical Cancer Cells by Ubiquitinating and Degrading SOCS1. Biochem Genet 2024 Jun 25;","DOI":"10.1007\/s10528-024-10865-8"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Saha S, Sultana S, Rahmat R, Akther T, Nessa A, Jahan M. Patterns of Different Cervical Cytokine Expression in High-Risk Human Papillomavirus-Infected Patients With Cervical Cancer and Its Precancerous Lesions. Clin Med Insights Oncol 2025 Mar 25; 19: 11795549251316767;","DOI":"10.1177\/11795549251316767"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Fujii T Nishio E, Tsukamoto T Kukimoto I, Iwata A. Performance of an ancillary test for cervical cancer that measures miRNAs and cytokines in serum and cervical mucus. Cancer Sci 2024 Aug; 115(8): 2795-807;","DOI":"10.1111\/cas.16214"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Simanullang RH, Situmorang PC, Herlina M, Noradina, Silalahi B, Manurung SS. Histological changes of cervical tumours following Zanthoxylum acanthopodium DC treatment, and its impact on cytokine expression. Saudi J Biol Sci 2022 Apr; 29(4): 2706-18;","DOI":"10.1016\/j.sjbs.2021.12.065"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Ao L, Shi J, Gan J, Yu W, Du H. Effects of dexmedetomidine and ketorolac applied for patient controlled analgesia on the balance of Th1\/Th2 and level of VEGF in patients undergoing laparoscopic surgery for cervical cancer: A randomised controlled trial. Oncol Lett 2024 Jun 17; 28(2): 379;","DOI":"10.3892\/ol.2024.14512"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhu J, Feng R, Han M, Chen F Hu Y Altered vaginal cervical microbiota diversity contributes to HPV-induced cervical cancer via inflammation regulation. PeerJ 2024 Jun 12; 12: e17415;","DOI":"10.7717\/peerj.17415"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Molina MA, Steenbergen RDM, Pumpe A, Kenyon AN, Melchers WJG. HPV integration and cervical cancer: a failed evolutionary viral trait. Trends Mol Med 2024 Sep; 30(9): 890-902;","DOI":"10.1016\/j.molmed.2024.05.009"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Wu L, Zheng Y Liu J, Luo R, Wu D, Xu P Wu D, Li X. Comprehensive evaluation of the efficacy and safety of LPV\/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19. Aging (Albany NY) 2021 Apr 20; 13(8): 10833-52;","DOI":"10.18632\/aging.202860"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Bhattacharjee R, Das SS, Biswal SS, Nath A, Das D, Basu A, Malik S, Kumar L, Kar S, Singh SK, Upadhye VJ, Iqbal D, Almojam S, Roychoudhury S, Ojha S, Ruokolainen J, Jha NK, Kesari KK. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies. Crit Rev Oncol Hematol 2022 Jun; 174: 103675;","DOI":"10.1016\/j.critrevonc.2022.103675"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Hernandez-Silva CD, Ramirez de Arellano A, Pereira-Suarez AL, Ramfrez-Lopez IG. HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women. Viruses 2024 Feb 21; 16(3): 327;","DOI":"10.3390\/v16030327"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Wu L, Zhong Y, Wu D, Xu P Ruan X , Yan J, Liu J, Li X. Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines 2022 Sep 10; 10(9): 2248;","DOI":"10.3390\/biomedicines10092248"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Wtoszek E, Krupa K, Skrok E, Budzik MP Deptafa A, Badowska-Kozakiewicz A. HPV and Cervical Cancer-Biology, Prevention, and Treatment Updates. Curr Oncol 2025 Feb 22; 32(3): 122;","DOI":"10.3390\/curroncol32030122"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Dorji T, Tshomo U, Gyamtsho S, Tamang ST, Wangmo S, Pongpirul K. Gender-neutral HPV elimination, cervical cancer screening, and treatment: Experience from Bhutan. Int J Gynecol Obstet 2022 Mar; 156(3): 425-9;","DOI":"10.1002\/ijgo.13728"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Wu L, Liu Q, Ruan X , Luan X , Zhong Y Liu J, Yan J, Li X. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD). Biomedicines 2023 Jun 29; 11(7): 1861;","DOI":"10.3390\/biomedicines11071861"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Ueda Y Epidemiology of cervical cancer and HPV infection in Asia and Oceania. J Obstet Gynecol Res 2024 Oct; 50 Suppl 1: 31-41;","DOI":"10.1111\/jog.15943"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Kombe AJK, Zoa-Assoumou S, Bounda GA, Nsole-Biteghe FA, Jin T, Zour\u00e9 AA. Advances in Etio-pathological Role and Control of HPV in Cervical Cancer Oncogenesis. Front Biosci (Landmark Ed) 2023 Oct 19; 28(10): 245;","DOI":"10.31083\/j.fbl2810245"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Ni H, Huang C, Ran Z, Li S, Kuang C, Zhang Y, Yuan K. Targeting HPV for the prevention, diagnosis, and treatment of cervical cancer. J Mol Cell Biol 2025 May 2; 16(10): mjae046;","DOI":"10.1093\/jmcb\/mjae046"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Wu L, Zheng Y, Ruan X, Wu D, Xu P , Liu J, Wu D, Li X. Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model. Anticancer Drugs 2022 Jan 1; 33(1): e590-e603;","DOI":"10.1097\/CAD.0000000000001189"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Ginindza TG, Forestier M, Almonte M. Cervical cancer screening by visual inspection and HPV testing in Eswatini. Prev Med 2022 Aug; 161: 107144;","DOI":"10.1016\/j.ypmed.2022.107144"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Gu Y, Li T, Zhang M, Chen J, Shen F , Ding J, Zhou G, Hua K. The Display between HPV Infection and Host Immunity in Cervical Cancer. Front Biosci (Landmark Ed) 2024 Dec 24; 29(12): 426;","DOI":"10.31083\/j.fbl2912426"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Sasieni P Castanon A. HPV vaccination and cervical cancer screening - Authors' reply. Lancet 2022 May 21; 399(10339): 1940;","DOI":"10.1016\/S0140-6736(22)00240-9"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Wu L, Zhong Y, Yu X , Wu D, Xu P Lv L, Ruan X , Liu Q, Feng Y, Liu J, Li X. Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research. Anticancer Drugs 2022 Oct 1; 33(9): 943-59;","DOI":"10.1097\/CAD.0000000000001319"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Primena serumskih Th1\/Th2 citokina u kombinaciji sa tumorskim markerima u dijagnostici karcinoma grli\u0107a materice pozitivnog na HR-HPV"],"language":"en","link":[{"URL":"https:\/\/aseestant.ceon.rs\/index.php\/jomb\/article\/download\/59352\/28541","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2026\/1452-82582603579C.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T21:16:52Z","timestamp":1773782212000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582603579C"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-59352","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}